Konstantin Kondratchik
Overview
Explore the profile of Konstantin Kondratchik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
25
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Demina I, Mikhailova E, Zerkalenkova E, Semchenkova A, Roumiantseva J, Borkovskaya A, et al.
Am J Clin Pathol
. 2024 Mar;
162(2):180-190.
PMID: 38513276
Objectives: Mixed-phenotype acute leukemia (MPAL) is a rare disease associated with difficulties in the correct lineage assignment of leukemic cells. One of the least common subtypes within this category is...
2.
Fechina L, Popov A, Tsaur G, Henze G, Shorikov E, Makarova O, et al.
Leukemia
. 2023 Sep;
37(11):2276-2281.
PMID: 37741948
No abstract available.
3.
Popov A, Tsaur G, Permikin Z, Henze G, Verzhbitskaya T, Plekhanova O, et al.
Pediatr Blood Cancer
. 2023 Jan;
70(4):e30204.
PMID: 36715125
The aim of this study was to present the diagnostic and outcome characteristics of infants with germline status of KMT2A gene (KMT2A-g) B-cell precursor acute lymphoblastic leukemia (BCP-ALL) treated consistently...
4.
Popov A, Tsaur G, Permikin Z, Fominikh V, Verzhbitskaya T, Riger T, et al.
Pediatr Blood Cancer
. 2022 Jun;
69(9):e29860.
PMID: 35713168
Aim: The aim of the study was to evaluate the incidence and prognostic impact of central nervous system (CNS) involvement in infants with B-cell precursor acute lymphoblastic leukemia (BCP-ALL), as...
5.
Semchenkova A, Mikhailova E, Komkov A, Gaskova M, Abasov R, Matveev E, et al.
Int J Mol Sci
. 2022 Apr;
23(7).
PMID: 35409391
We report incidence and deep molecular characteristics of lineage switch in 182 pediatric patients affected by B-cell precursor acute lymphoblastic leukemia (BCP-ALL), who were treated with blinatumomab. We documented six...
6.
Popov A, Tsaur G, Verzhbitskaya T, Riger T, Permikin Z, Demina A, et al.
Br J Haematol
. 2021 Dec;
201(3):510-519.
PMID: 34970734
This study aimed to evaluate the concordance between minimal residual disease (MRD) results obtained by multicolour flow cytometry (MFC) and polymerase chain reaction for fusion gene transcripts (FGTs) in infants...
7.
Tsaur G, Popov A, Riger T, Kustanovich A, Solodovnikov A, Shorikov E, et al.
Br J Haematol
. 2021 Feb;
193(6):1151-1156.
PMID: 33583020
The prognostic value of minimal residual disease (MRD) measured by fusion-gene transcript (FGT) detection was investigated in 76 infants (aged ≤1 year) with acute lymphoblastic leukaemia (ALL) with lysine methyltransferase...
8.
Popov A, Buldini B, De Lorenzo P, Disaro S, Verzhbitskaya T, Movchan L, et al.
Leukemia
. 2020 Jun;
34(11):3042-3046.
PMID: 32533093
No abstract available.
9.
Karachunskiy A, Tallen G, Roumiantseva J, Lagoiko S, Chervova A, von Stackelberg A, et al.
J Cancer Res Clin Oncol
. 2019 Mar;
145(4):1001-1012.
PMID: 30840197
Purpose: Favorable outcomes were achieved for children with acute lymphoblastic leukemia (ALL) with the first Russian multicenter trial Moscow-Berlin (ALL-MB) 91. One major component of this regimen included a total...